Glenmark receives FDA OK for generic Nexium
Esomeprazole magnesium delayed-release capsules, 20 mg (OTC), will be distributed in the United States by Glenmark Therapeutics.
Glenmark has received The Food & Drug Administration’s permission for esomeprazole magnesium delayed-release capsules, 20 mg (OTC), which is the generic of Haleon’s Nexium 24 HR Delayed-Release Capsules.
Esomeprazole magnesium delayed-release capsules, 20 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics.
[Read more FDA grants Glenmark tentative approval for generic Enstilar]
Nexium 24 HR Delayed-Release Capsules, 20 mg (OTC) had a market value of approximately $259.2 million, per Nielsen syndicated data for the latest 52 weeks period ending May 18, 2024.